Ambros Therapeutics

ambrostherapeutics.com

ambrostherapeutics.com • 201-500 employees • Likely startup • New

201-500 employees • Likely startup • New

Actively hiring

Rare Disease Therapeutics

Biotechnology

Overview

Salaries

Products

People

Growth

Offices

Financials

Funding and backers

Team

201-500

employees, estimated range

Backers

RA Capital Management

Momentum

0/100

no fresh signals

Backed byfrom the funds' portfolios and accelerator catalogs

RA Capital Management fund

Similar startupsby what they do, their industry and backers

GEn1E LifesciencesFounded 2018

US FDA Grants Orphan Drug and Rare Pediatric Disease Designations to GEn1E Lifesciences' Dual Signal Modulator for the Treatment of…

MinoryxVenture round $55.1M · 4 yr ago • 51-200 employees

Minoryx is focused on the discovery and development of novel treatments for severe, orphan diseases of the central nervous system with high…

Egetis TherapeuticsFounded 2018

Egetis is an innovative and integrated pharmaceutical company, focusing on projects in late-stage development for commercialization for…

AffiniaTX51-200 employees

Affinia Therapeutics is expanding what's possible in adeno-associated virus (AAV) gene therapy today and bringing transformative medicines…

Angitia Biopharmaceuticals

Angitia is a clinical-stage biotechnology company focused on discovering and developing breakthrough therapeutics that address the key…

NMD Pharma51-200 employees

0 Enable better lives through novel therapies to restore skeletal muscle health About NMD Pharma NMD Pharma is a clinical-stage biotech…

Overview

Overview. Ambros Therapeutics, headquartered in San Diego, California, is a clinical-stage biotechnology company focused on the development of innovative and transformative medicines for diseases with a high unmet medical need.